MOONWALK BIOSCIENCES
Live / Registered — Registered (as of 31 Mar 2026)
What this means for you
Registered since 31 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98977812
- Registration number
- 8198362
- Mark type
- Stylized text
- Filed
- 02 Oct 2023
- Published for opposition
- 07 Jan 2025
- Registered
- 31 Mar 2026
- Attorney of record
- Michael J. Allan
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceuticals, therapeutics, and biotechnology; Conducting research and clinical trials for others relating to pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, pediatric, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases; Conducting research and clinical trials for others relating to veterinary pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases
Owner
- Moonwalk Biosciences, South San Francisco, CA, US
- Moonwalk Biosciences, South San Francisco, CA, US
- Moonwalk Biosciences, South San Francisco, CA, US
Prosecution history
- 31 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 10 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Jul 2025 — USE AMENDMENT FILED
- 06 Mar 2026 — DIVISIONAL PROCESSING COMPLETE
- 11 Jul 2025 — DIVISIONAL REQUEST RECEIVED
- 06 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 11 Jul 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED